Nordicnanovector Revenue and Competitors
Estimated Revenue & Valuation
- Nordicnanovector's estimated annual revenue is currently $3.1M per year.
- Nordicnanovector's estimated revenue per employee is $155,000
Employee Data
- Nordicnanovector has 20 Employees.
- Nordicnanovector grew their employee count by -66% last year.
Nordicnanovector's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CSO | Reveal Email/Phone |
Nordicnanovector Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $16.4M | 106 | 29% | N/A | N/A |
#2 | $1.7M | 11 | -15% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $3.1M | 20 | -66% | N/A | N/A |
#5 | $5.4M | 35 | 9% | N/A | N/A |
#6 | $7M | 45 | 2% | N/A | N/A |
#7 | $9.8M | 63 | -14% | N/A | N/A |
#8 | $8.5M | 55 | 28% | N/A | N/A |
What Is Nordicnanovector?
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nordicnanovector News
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer...
Nordic Nanovector ASA Announces Proposed Board Changes - Former Algeta CEO Thomas Ramdahl nominated to Join Board of Directors.
Nordic Nanovector ASA - Notice of Annual General Meeting on 28 April 2022. Published: Apr 06, 2022. OSLO, Norway, April 6, 2022 /PRNewswire/ -- Notice is...
Other Companies in Oslo
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 20 | -5% | N/A |
#2 | $1.7M | 20 | 11% | N/A |
#3 | $2.1M | 21 | 11% | N/A |
#4 | $3.6M | 21 | 0% | N/A |
#5 | $4M | 21 | 17% | N/A |